Literature DB >> 18327361

Urinary trypsin inhibitor treatment ameliorates acute lung and liver injury resulting from sepsis in a rat model.

Li-Wen Zhou1, Yan-Lin Wang, Xue-Tao Yan, Xiang-Hu He.   

Abstract

OBJECTIVE: To evaluate the protective effect of urinary trypsin inhibitor (UTI) on acute lung and liver injury in rat model induced by sepsis with infra-abdominal infection.
METHODS: This study was performed in the University of Wuhan, Wuhan, China in May 2007. Sepsis models were made by cecal ligation and puncture (CLP) in Sprague-Dawley rats. Forty rats were randomly divided into sham, CLP, CLP/UTI I (20 u/g) and CLP/UTI II (50 u/g) groups, with 10 rats in each. All of them were sacrificed 12 hours after CLP. The mean arterial pressure (MAP), heart rate (HR), the wet-to-dry lung weight ratio (W/D) was measured and venous blood was collected for assaying tumor necrosis factor-alpha (TNF-alpha), interleukin-10 (IL-10), alanine aminotransferase (ALT), aspartate aminotransferase (AST) and lactic acid. Superoxide dismutase (SOD), malondialdehyde (MDA) and expression of inducible nitric oxide synthase (iNOS) mRNA in lung and hepatic tissues were examined.
RESULTS: Compared with the CLP group, MAP and HR in 50 u/g UTI treated rats was stable (p<0.01). Marked elevation levels of W/D ratio were lowered after administration of 50 u/g UTI (p<0.01). Treatment with 50 u/g UTI prevented marked elevation in MDA, ALT, AST, TNF-alpha, lactic acid levels, expression of iNOS mRNA, and elevated IL-10 and SOD activity (p<0.01).
CONCLUSION: Urinary trypsin inhibitor has a protective effect against sepsis. Its action mechanisms are probably involved in the inhibition of inflammatory factor production and suppression of lipid peroxidation and iNOS mRNA expression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18327361

Source DB:  PubMed          Journal:  Saudi Med J        ISSN: 0379-5284            Impact factor:   1.484


  10 in total

Review 1.  Anti-inflammatory actions of serine protease inhibitors containing the Kunitz domain.

Authors:  Hiroshi Shigetomi; Akira Onogi; Hirotaka Kajiwara; Shozo Yoshida; Naoto Furukawa; Shoji Haruta; Yasuhito Tanase; Seiji Kanayama; Taketoshi Noguchi; Yoshihiko Yamada; Hidekazu Oi; Hiroshi Kobayashi
Journal:  Inflamm Res       Date:  2010-05-08       Impact factor: 4.575

2.  Expression of heat shock protein 70 in lung tissues of acute paraquat poisoned rats and intervention of ulinastatin.

Authors:  Zhi-Jian Zhang; Cong-Yang Zhou; Ya-Juan Luo; Hua-Wei Xiong
Journal:  World J Emerg Med       Date:  2010

3.  Ulinastatin attenuates protamine-induced cardiotoxicity in rats by inhibiting tumor necrosis factor alpha.

Authors:  Hisashi Fukushima; Takeshi Oguchi; Hiroaki Sato; Yosuke Nakadate; Tamaki Sato; Keisuke Omiya; Akiko Kawakami; Toru Matsuoka; Takashi Matsukawa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-10-08       Impact factor: 3.000

4.  Role of serine protease inhibitor, ulinastatin, in rat model of hepatic encephalopathy: aquaporin 4 molecular targeting and therapeutic implication.

Authors:  Rehab E Abo El Gheit; Marwa Mohamed Atef; Ghada A Badawi; Walaa M Elwan; H A Alshenawy; Marwa Nagy Emam
Journal:  J Physiol Biochem       Date:  2020-08-14       Impact factor: 4.158

5.  Exogenous inter-α inhibitor proteins prevent cell death and improve ischemic stroke outcomes in mice.

Authors:  Louise D McCullough; Meaghan Roy-O'Reilly; Yun-Ju Lai; Anthony Patrizz; Yan Xu; Juneyoung Lee; Aleah Holmes; Daniel C Kraushaar; Anjali Chauhan; Lauren H Sansing; Barbara S Stonestreet; Liang Zhu; Julia Kofler; Yow-Pin Lim; Venugopal Reddy Venna
Journal:  J Clin Invest       Date:  2021-09-01       Impact factor: 14.808

6.  Effects of ulinastatin combined with mechanical ventilation on oxygen metabolism, inflammation and stress response and antioxidant capacity of ARDS.

Authors:  Mingxia Ji; Tiejiang Chen; Baiming Wang; Mengyan Chen; Qianqian Ding; Lingchao Chen; Yuejuan Fang; Xiaofang Yu; Yanzhen Chen; Xiaohua Wang; Yiyue He; Yong Jiang
Journal:  Exp Ther Med       Date:  2018-03-30       Impact factor: 2.447

7.  Ulinastatin Ameliorates Pulmonary Capillary Endothelial Permeability Induced by Sepsis Through Protection of Tight Junctions via Inhibition of TNF-α and Related Pathways.

Authors:  Ming Fang; Wen-Hong Zhong; Wen-Liang Song; Yi-Yu Deng; Duo-Meng Yang; Bin Xiong; Hong-Ke Zeng; Hua-Dong Wang
Journal:  Front Pharmacol       Date:  2018-08-13       Impact factor: 5.810

8.  Atypical reactive center Kunitz-type inhibitor from the sea anemone Heteractis crispa.

Authors:  Irina Gladkikh; Margarita Monastyrnaya; Elena Leychenko; Elena Zelepuga; Victoria Chausova; Marina Isaeva; Stanislav Anastyuk; Yaroslav Andreev; Steve Peigneur; Jan Tytgat; Emma Kozlovkaya
Journal:  Mar Drugs       Date:  2012-07-19       Impact factor: 6.085

9.  Ulinastatin suppresses burn-induced lipid peroxidation and reduces fluid requirements in a Swine model.

Authors:  Hong-Min Luo; Ming-Hua Du; Zhi-Long Lin; Quan Hu; Lin Zhang; Li Ma; Huan Wang; Yu Wen; Yi Lv; Hong-Yuan Lin; Yu-Li Pi; Sen Hu; Zhi-Yong Sheng
Journal:  Oxid Med Cell Longev       Date:  2013-04-24       Impact factor: 6.543

10.  Urinary Trypsin Inhibitor Protects Tight Junctions of Septic Pulmonary Capillary Endothelial Cells by Regulating the Functions of Macrophages.

Authors:  Ruijie Wang; Wenliang Song; Chengyuan Xie; Wenhong Zhong; Hui Xu; Qiuping Zhou; Yiyu Deng; Yimei Hong; Xin Li; Ming Fang
Journal:  J Inflamm Res       Date:  2021-05-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.